Skip to main content
Gregory Monohan, MD, Oncology, Lexington, KY

GregoryPatrickMonohanMD

Oncology Lexington, KY

Professor, Internal Medicine, University of Kentucky College of Medicine

Dr. Monohan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Monohan's full profile

Already have an account?

  • Office

    800 Rose Street
    CC446 Roach Bldg UK Hematology Clinic
    Lexington, KY 40536
    Phone+1 859-257-6006
    Fax+1 859-257-6002

Summary

  • Dr. Gregory Monohan is an oncologist in Lexington, KY and is affiliated with University of Kentucky Albert B. Chandler Hospital. He received his medical degree from University of Kentucky College of Medicine and has been in practice 17 years. He specializes in hematologic oncology and is experienced in hematologic oncology and stem cell transplantation.

Education & Training

  • University of Kentucky College of Medicine
    University of Kentucky College of MedicineFellowship, Hematology and Medical Oncology, 2003 - 2006
  • Indiana University School of Medicine
    Indiana University School of MedicineResidency, Internal Medicine, 2000 - 2003
  • University of Kentucky College of Medicine
    University of Kentucky College of MedicineClass of 2000

Certifications & Licensure

  • KY State Medical License
    KY State Medical License 2003 - 2025
  • American Board of Internal Medicine Hematology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Age Adjusted Hematopoietic Stem Cell Transplant Comorbidity Index Predicts Survival in a T-cell Depleted Cohort☆  
    Swati Yalamanchi, Hayder Saeed, Dianna Howard, Gerhard C Hildebrandt, Roger Herzig, Gregory Monohan, ScienceDirect
  • Phase I Study of the Investigational Aurora A Kinase Inhibitor Alisertib plus Rituximab or Rituximab/vincristine in Relapsed/refractory Aggressive B-cell Lymphoma  
    Daniel Persky, Soham Puvvada, Catherine Spier, Gregory Monohan, Ari VanderWalde, Daruka Mahadevan, Clinical Cancer Research

Abstracts/Posters

  • Disparities in Plasma Cell Neoplasms in Kentucky, Appalachia and Other States: A Population Based Study
    Gregory Monohan, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Professional Memberships